Published in Proc Natl Acad Sci U S A on August 01, 1974
Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice. J Virol (1980) 1.85
Structural proteins of mammalian oncogenic RNA viruses: immunological characterization of the p15 polypeptide of Rauscher murine virus. J Virol (1974) 1.61
Viral proteins expressed on the surface of murine leukemia cells. J Virol (1977) 1.60
Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag- and env-gene products. Proc Natl Acad Sci U S A (1977) 1.43
Differential expression of helper viral structural polypeptides in cells transformed by clonal isolates of woolly monkey sarcoma virus. J Virol (1975) 1.22
Characterization of a progressive neurodegenerative disease induced by a temperature-sensitive Moloney murine leukemia virus infection. J Virol (1986) 1.17
Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. J Exp Med (1976) 0.98
In vitro transformation of mouse bone marrow cells by the polycythemic strain of Friend leukemia virus. Proc Natl Acad Sci U S A (1979) 0.96
Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related. J Virol (1984) 0.96
55,000-dalton, retrovirus-associated, cell membrane glycoprotein: purification and quantitative measurements of expression in viruses, cells, and tissues. Mol Cell Biol (1981) 0.78
Replication-defective Friend murine leukemia virus particles containing uncleaved gag polyproteins and decreased levels of envelope glycoprotein. J Virol (1981) 0.78
Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses. Proc Natl Acad Sci U S A (1966) 5.34
Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J Virol (1973) 5.28
Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen. J Biol Chem (1973) 5.05
RNA in mammalian sarcoma virus transformed nonproducer cells homologous to murine leukemia virus RNA. Virology (1973) 5.04
Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells. J Gen Virol (1971) 5.01
A nonselective analysis of SV40 transformation of mouse 3T3 cells. Virology (1974) 4.37
Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science (1968) 4.00
Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol (1974) 3.91
ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS. Proc Natl Acad Sci U S A (1964) 3.77
Proteins of helper-dependent RSV. Virology (1971) 3.62
ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS. 3. DETERMINING INFLUENCE OF A NEW HELPER VIRUS ON THE HOST RANGE AND SUSCEPTIBILITY TO INTERFERENCE OF RSV. Virology (1965) 2.71
Evidence for helper independent murine sarcoma virus. I. Segregation of replication-defective and transformation-defective viruses. Virology (1973) 2.67
Rescue of the genome of focus forming virus from rat non-productive lines by 5'-bromodeoxyruidine. Nat New Biol (1971) 2.51
Viral RNA subunits in cells transformed by RNA tumor viruses. Science (1972) 2.44
Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26
Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein. J Virol (1974) 1.87
Mammalian cells in culture frequently release type C viruses. Science (1973) 1.79
Immunological characterization of a low molecular weight polypeptide of murine leukemia virus. Virology (1973) 1.70
Partial transcription of murine type C viral genomes in BALB c cell lines. J Virol (1973) 1.61
Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology (1972) 1.59
Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells. J Virol (1972) 1.44
Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV. Nat New Biol (1972) 1.44
Presence of sarcoma genome in a "non-infectious" mammalian virus. Nat New Biol (1971) 1.39
Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol (1971) 1.32
Morphologic revertants of murine sarcoma virus transformed nonproducer BALB-3T3: selective techniques for isolation and biologic properties in vitro and in vivo. Virology (1974) 1.20
Differences in susceptibility of human cells to mouse sarcoma virus. J Natl Cancer Inst (1971) 1.11
Deficiency of viral ribonucleic acid-dependent deoxyribonucleic acid polymerase in noninfectious virus-like particles released from murine sarcoma virus-transformed hamster cells. J Virol (1972) 1.09
Isolation and characterization of a primate sarcoma virus: mechanism of rescue. Int J Cancer (1973) 1.03
Properties of flat variants of murine sarcoma virus transformed non-producer cells isolated after high-temperature passage. Int J Cancer (1974) 0.88
Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey). J Natl Cancer Inst (1972) 0.82
Heterogeneity of virus production and antigenicity detected in cell clones derived from a "nonproducer" neoplasm induced by Moloney murine sarcoma virus. J Natl Cancer Inst (1974) 0.78
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 6.03
Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen. J Biol Chem (1973) 5.05
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
Identification of two lysosomal membrane glycoproteins. J Cell Biol (1985) 4.08
Factor fraction required for the synthesis of bacteriophage Qbeta-RNA. Nature (1968) 4.02
Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol (1974) 3.91
Studies on reovirus RNA. I. Characterization of reovirus genome RNA. J Mol Biol (1967) 3.88
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Bacterial proteins required for replication of phage Q ribonucleic acid. Pruification and properties of host factor I, a ribonucleic acid-binding protein. J Biol Chem (1972) 3.45
Protein kinase and phosphate acceptor proteins in Rauscher murine leukaemia virus. Nat New Biol (1971) 2.96
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release (2001) 2.84
High molecular weight precursor polypeptides to structural proteins of Rauscher murine leukemia virus. J Mol Biol (1976) 2.72
Structural proteins of ribonucleic acid tumor viruses. Purification of envelope, core, and internal components. J Biol Chem (1976) 2.31
Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains. Proc Natl Acad Sci U S A (1974) 2.28
Lateral diffusion of an 80,000-dalton glycoprotein in the plasma membrane of murine fibroblasts: relationships to cell structure and function. J Cell Biol (1984) 2.28
Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci U S A (1995) 2.27
Further evidence for deletion of envelope glycoprotein (gp69/71) sequences in formation of Moloney-murine sarcoma virus. J Gen Virol (1978) 2.22
A promoter deletion reduces the rate of mitotic, but not meiotic, recombination at the HIS4 locus in yeast. Curr Genet (1992) 2.13
A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir). AIDS (1996) 2.03
Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing onco-differentiation antigens. J Biol Chem (1988) 1.96
Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30. J Virol (1974) 1.95
Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys (1989) 1.90
Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables. J Infect Dis (1998) 1.89
Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein. J Virol (1974) 1.87
Stoichiometry and specificity of binding of Rauscher oncovirus 10,000-dalton (p10) structural protein to nucleic acids. J Virol (1978) 1.83
Characterization of plasma membrane proteins identified by monoclonal antibodies. J Biol Chem (1981) 1.83
Temperature-induced fluorescence changes : a screening method for frost tolerance of potato (solanum sp.). Plant Physiol (1982) 1.78
Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man. Proc Natl Acad Sci U S A (1985) 1.70
The biochemistry of RNA bacteriophage replication. Annu Rev Biochem (1970) 1.69
The human lymphocyte function-associated (HLFA) antigen and a related macrophage differentiation antigen (HMac-1): functional effects of subunit-specific monoclonal antibodies. J Immunol (1985) 1.67
Murine cell surface glycoproteins. Characterization of a major component of 80,000 daltons as a polymorphic differentiation antigen of mesenchymal cells. J Biol Chem (1981) 1.66
Oncornavirus envelope glycoprotein in serum of mice. Virology (1976) 1.64
Structural proteins of mammalian oncogenic RNA viruses: immunological characterization of the p15 polypeptide of Rauscher murine virus. J Virol (1974) 1.61
Redistribution of a major cell surface glycoprotein during cell movement. J Cell Biol (1984) 1.60
Resolution of two factors required in the Q-beta-RNA polymerase reaction. Nature (1968) 1.59
The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1. J Biol Chem (1993) 1.58
Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc Natl Acad Sci U S A (1988) 1.56
Postfixation detergent treatment for immunofluorescence suppresses localization of some integral membrane proteins. J Histochem Cytochem (1985) 1.55
DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release (1998) 1.46
Polyembryonic development: insect pattern formation in a cellularized environment. Development (1996) 1.43
Replication of RNA viruses. X. Replication of a natural 6 s RNA by the Q-beta RNA polymerase. J Mol Biol (1969) 1.42
Stable and heritable inhibition of the expression of nopaline synthase in tobacco expressing antisense RNA. Proc Natl Acad Sci U S A (1987) 1.41
Alterations in glucose metabolism in chick-embryo cells transformed by Rous sarcoma virus: intracellular levels of glycolytic intermediates. Proc Natl Acad Sci U S A (1974) 1.39
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable. J Infect Dis (2001) 1.38
Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. J Immunol (1991) 1.38
Biochemical and immunological characterization of the major envelope glycoprotein gp69/71 and degradation fragments from Rauscher leukemia virus. J Virol (1977) 1.37
Innate immunity and its evasion and suppression by hymenopteran endoparasitoids. Bioessays (2001) 1.37
Coprecipitation of heat shock proteins with a cell surface glycoprotein. Proc Natl Acad Sci U S A (1982) 1.33
Lysosome-associated membrane proteins: characterization of LAMP-1 of macrophage P388 and mouse embryo 3T3 cultured cells. Arch Biochem Biophys (1985) 1.32
Nucleoside analog 1592U89 and human immunodeficiency virus protease inhibitor 141W94 are synergistic in vitro. Antimicrob Agents Chemother (1998) 1.31
A kinetic analysis of biosynthesis and localization of a lysosome-associated membrane glycoprotein. Arch Biochem Biophys (1986) 1.30
Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J Immunol (1990) 1.30
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry (2011) 1.27
Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. J Immunol (1990) 1.27
Type-C RNA virus gene expression in human tissue. J Virol (1974) 1.26
Mechanism of synthesis of bacteriophage RNA. Nature (1969) 1.23
Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol (1989) 1.22
Glycoproteins of coated pits, cell junctions, and the entire cell surface revealed by monoclonal antibodies and immunoelectron microscopy. J Cell Biol (1983) 1.21
Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother (1993) 1.21
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg (1998) 1.20
Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol (1996) 1.20
Murine cell surface glycoproteins. Purification of the polymorphic Pgp-1 antigen and analysis of its expression on macrophages and other myeloid cells. J Biol Chem (1983) 1.20
The 3'-terminus and the replication of phage RNA. Nature (1969) 1.18
Expression of CD44 in human lung tumors. Cancer Res (1994) 1.18
Characterization of a progressive neurodegenerative disease induced by a temperature-sensitive Moloney murine leukemia virus infection. J Virol (1986) 1.17
Polypeptides of cells transformed by RNA or DNA tumor viruses. Proc Natl Acad Sci U S A (1977) 1.17
Pharmacodynamics of abacavir in an in vitro hollow-fiber model system. Antimicrob Agents Chemother (2002) 1.16
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15
Phosphorylation of animal virus proteins by a virion protein kinase. J Virol (1973) 1.15
Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science (1982) 1.14
Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol (1986) 1.13
CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys (1994) 1.13
Prediction of class I T-cell epitopes: evidence of presence of immunological hot spots inside antigens. Bioinformatics (2004) 1.13
Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J Immunol (1995) 1.12
Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun (2000) 1.12
Replication of RNA viruses. V. Template activity of synthetic ribopolymers in the Q-beta RNA polymerase reaction. Proc Natl Acad Sci U S A (1967) 1.11
Cellular membrane receptors for oncovirus envelope glycoprotein: properties of the binding reaction and influence of different reagents on the substrate and the receptors. Arch Biochem Biophys (1978) 1.11
IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol (1996) 1.11
Lysosomal membrane glycoproteins: properties of LAMP-1 and LAMP-2. Biochem Soc Symp (1986) 1.10
Polypeptide maps of cells infected with murine type C leukemia or sarcoma oncovirus. Cell (1978) 1.10
A brain membrane protein similar to the rat src gene product. Proc Natl Acad Sci U S A (1981) 1.08
Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni. J Biol Chem (1991) 1.08
Mechanism of action of gliotoxin: elimination of activity by sulfhydryl compounds. Antimicrob Agents Chemother (1972) 1.08